Skip to content
  • Instagram
  • YouTube
  • X

PharmaBR.News

  • About Us

Access to medicines

  • Brazil’s CMED debates new pricing models for advanced therapies
    21 de March de 2026

    Brazil’s CMED debates new pricing models for advanced therapies

    pietrorubin
  • Brazil to launch national medication platform to strengthen judicial and administrative decision-making
    3 de December de 2025

    Brazil to launch national medication platform to strengthen judicial and administrative decision-making

    pietrorubin
  • Brazil hospital expands risk-sharing agreements to broaden access to innovative cancer therapies
    29 de November de 2025

    Brazil hospital expands risk-sharing agreements to broaden access to innovative cancer therapies

    pietrorubin
  • Brazil’s Farmácia Popular boosts sales and draws even premium pharmacy chains
    26 de November de 2025

    Brazil’s Farmácia Popular boosts sales and draws even premium pharmacy chains

    pietrorubin
  • Brazil still has drugs approved for the SUS that remain unavailable after more than two years
    16 de November de 2025

    Brazil still has drugs approved for the SUS that remain unavailable after more than two years

    pietrorubin
  • Brazil sets reimbursement value for cyclin-inhibitor therapies in the SUS, but access concerns remain
    14 de November de 2025

    Brazil sets reimbursement value for cyclin-inhibitor therapies in the SUS, but access concerns remain

    pietrorubin

Categories

Reviews.

News.

Guides.

Deals.

Videos.

Reader Poll.

Features.

Staff Picks.

Game Culture.

Podcast.

At PharmaBR.News, we highlight key developments in Brazil’s pharmaceutical and health policy landscape.

Get our free weekly briefing straight to your inbox.

  • Instagram
  • YouTube
  • X
  • About Us

Designed with WordPress

Loading Comments...